Glenn Noronha

Title: Glenn Noronha: Innovator in Ocular Treatment Technologies

Introduction

Glenn Noronha is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of ocular disease treatment. With a total of four patents to his name, he has developed innovative methods and devices aimed at improving the administration of drug formulations for ocular disorders.

Latest Patents

One of Glenn Noronha's latest patents focuses on methods and devices for the treatment of ocular diseases in human subjects. This invention provides targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye. The method involves inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the microneedle into the SCS. The infused drug formulation is designed to flow within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles, enhancing the effectiveness of the treatment.

Career Highlights

Throughout his career, Glenn Noronha has worked with notable companies in the biotechnology sector, including Clearside Biomedical, Inc. and Copernicus Therapeutics, Inc. His work has significantly advanced the understanding and treatment of ocular diseases, making him a key figure in this specialized field.

Collaborations

Glenn has collaborated with esteemed professionals in the industry, including Vladimir Zarnitsyn and Daniel White. These collaborations have further enriched his research and development efforts, leading to innovative solutions in ocular treatment.

Conclusion

Glenn Noronha's contributions to ocular disease treatment through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in non-surgical drug administration techniques, ultimately benefiting patients with ocular disorders.